TCTR20110000013招募中3 期
epafenac and Prevention of CME after Cataract Surgery in Patients Receiving Latanoprost: A Randomized Controlled Trial
Glaucoma Research Fund0 个研究点目标入组 80 人开始时间: 2011年5月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Eyes receiving 0.005% Latanoprost at least 1-month prior to a planned phacoemulsification with PC-IOL implantation; age over 18 years
排除标准
- •history of intra-ocular inflammation; CSME, or macular oedema of any aetiology; proliferative
- •diabetic retinopathy; retinitis pigmentosa; prior vitreo-retinal surgery; pregnancy;
- •known/suspicious allergy to NSAIDs/Prostaglandin analogues; physical/mental/intellectual
- •disabilities preventing from understanding and complying to protocol
研究者
相似试验
已完成
不适用
epafenac and prevention of cystoid macular edema (CME) after cataract surgery in patients receiving latanoprostCystoid macular edema (CME)Eye DiseasesOedemaISRCTN38025852Chulalongkorn University (Thailand)80
已完成
3 期
PRevention of Macular EDema After Cataract SurgeryDiabetes MellitusCataractCystoid Macular EdemaNCT01774474Maastricht University Medical Center1,127
已完成
不适用
Effect of Eye Care Protocol on the Prevention of Eye Surface Disorders in admitted Patientskeratitis, conjunctivitis , eye dryness ?corneal ulcer.IRCT20190522043671N1Ahvaz University of Medical Sciences70
进行中（未招募）
1 期
Prevention of macular edema after cataract surgeryEUCTR2012-004873-14-BEniversity Eye Clinic Maastricht UMC1,008
进行中（未招募）
1 期
Prevention of macular edema after cataract surgeryCystoid Macular Edema (CME) after cataract surgeryEUCTR2012-004873-14-NLniversity Eye Clinic Maastricht1,135